FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904327346> ?p ?o ?g. }

• W2904327346 endingPage "477" @default.
• W2904327346 startingPage "462" @default.
• W2904327346 abstract "Different prolonged-release formulations of tacrolimus are available. To date, the pharmacokinetic (PK) profile of LCP-tacrolimus (LCPT; Envarsus®) has not been compared with PR-Tac (Advagraf®) in de novo kidney transplant recipients. These profiles will guide clinical recommendations for the initiation and dose titration strategies of once-daily tacrolimus formulations. This randomized, parallel-group, open-label, multicenter PK study randomized 75 de novo, adult, white kidney transplant recipients to LCPT 0.17 mg/kg/day (n = 37) or PR-Tac 0.20 mg/kg/day (n = 38) for 4 weeks. Dose adjustments were permitted to target a pre-defined therapeutic range based on measured trough blood concentrations. PK analysis (days 1, 3, 7 and 14) included 68 patients (LCPT, n = 33; PR-Tac, n = 35). Similar proportions of patients were within the pre-defined therapeutic tacrolimus trough blood concentration range, with < 12% in each group having below-target trough levels over the study period. LCPT demonstrated ~ 30% greater relative bioavailability [LCPT/PR-Tac adjusted geometric mean ratio: day 3, 1.32 (p = 0.007); day 7, 1.25 (p = 0.051); day 14, 1.43 (p = 0.002)] and ~ 30% lower peak-to-trough percentage fluctuation of blood concentration [LCPT/PR-Tac adjusted geometric mean ratio: day 3, 0.70 (p < 0.001); day 7, 0.68 (p < 0.001); day 14, 0.73 (p = 0.004)] in addition to longer time to maximum blood concentration (tmax), lower maximum concentration (Cmax) and a consistently lower daily dose (~ 40% dose reduction with LCPT vs. PR-Tac by day 28). Safety profiles were similar. In de novo kidney transplant recipients, prolonged-release formulations of tacrolimus can reach therapeutic concentrations in the immediate post-transplant period. LCPT has greater relative bioavailability and lower peak-to-trough fluctuation compared with PR-Tac. Registered at ClinicalTrials.gov; study number NCT02500212. Chiesi Farmaceutici S.p.A." @default.
• W2904327346 created "2018-12-22" @default.
• W2904327346 creator A5011256855 @default.
• W2904327346 creator A5016087727 @default.
• W2904327346 creator A5020630930 @default.
• W2904327346 creator A5037597028 @default.
• W2904327346 creator A5041851717 @default.
• W2904327346 creator A5048414849 @default.
• W2904327346 creator A5060713243 @default.
• W2904327346 creator A5066608092 @default.
• W2904327346 creator A5068675262 @default.
• W2904327346 creator A5070397165 @default.
• W2904327346 creator A5070733450 @default.
• W2904327346 creator A5070982242 @default.
• W2904327346 creator A5077289325 @default.
• W2904327346 creator A5091017781 @default.
• W2904327346 creator A5091575574 @default.
• W2904327346 date "2018-12-14" @default.
• W2904327346 modified "2023-10-13" @default.
• W2904327346 title "Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study" @default.
• W2904327346 cites W1480151031 @default.
• W2904327346 cites W1582395273 @default.
• W2904327346 cites W1929309318 @default.
• W2904327346 cites W1962251849 @default.
• W2904327346 cites W1972829697 @default.
• W2904327346 cites W1974076557 @default.
• W2904327346 cites W1979814913 @default.
• W2904327346 cites W1979991882 @default.
• W2904327346 cites W1999400963 @default.
• W2904327346 cites W2007523308 @default.
• W2904327346 cites W2021775978 @default.
• W2904327346 cites W2027651668 @default.
• W2904327346 cites W2033139608 @default.
• W2904327346 cites W2047439727 @default.
• W2904327346 cites W2062166039 @default.
• W2904327346 cites W2126744966 @default.
• W2904327346 cites W2131404222 @default.
• W2904327346 cites W2155965977 @default.
• W2904327346 cites W2204234552 @default.
• W2904327346 cites W2232930881 @default.
• W2904327346 cites W2410226431 @default.
• W2904327346 cites W2463371736 @default.
• W2904327346 cites W2607031541 @default.
• W2904327346 cites W2770766047 @default.
• W2904327346 cites W2789871513 @default.
• W2904327346 cites W2915342131 @default.
• W2904327346 cites W4211117577 @default.
• W2904327346 cites W604985525 @default.
• W2904327346 doi "https://doi.org/10.1007/s12325-018-0855-1" @default.
• W2904327346 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6824349" @default.
• W2904327346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30552587" @default.
• W2904327346 hasPublicationYear "2018" @default.
• W2904327346 type Work @default.
• W2904327346 sameAs 2904327346 @default.
• W2904327346 citedByCount "21" @default.
• W2904327346 countsByYear W29043273462019 @default.
• W2904327346 countsByYear W29043273462020 @default.
• W2904327346 countsByYear W29043273462021 @default.
• W2904327346 countsByYear W29043273462022 @default.
• W2904327346 countsByYear W29043273462023 @default.
• W2904327346 crossrefType "journal-article" @default.
• W2904327346 hasAuthorship W2904327346A5011256855 @default.
• W2904327346 hasAuthorship W2904327346A5016087727 @default.
• W2904327346 hasAuthorship W2904327346A5020630930 @default.
• W2904327346 hasAuthorship W2904327346A5037597028 @default.
• W2904327346 hasAuthorship W2904327346A5041851717 @default.
• W2904327346 hasAuthorship W2904327346A5048414849 @default.
• W2904327346 hasAuthorship W2904327346A5060713243 @default.
• W2904327346 hasAuthorship W2904327346A5066608092 @default.
• W2904327346 hasAuthorship W2904327346A5068675262 @default.
• W2904327346 hasAuthorship W2904327346A5070397165 @default.
• W2904327346 hasAuthorship W2904327346A5070733450 @default.
• W2904327346 hasAuthorship W2904327346A5070982242 @default.
• W2904327346 hasAuthorship W2904327346A5077289325 @default.
• W2904327346 hasAuthorship W2904327346A5091017781 @default.
• W2904327346 hasAuthorship W2904327346A5091575574 @default.
• W2904327346 hasBestOaLocation W29043273461 @default.
• W2904327346 hasConcept C105795698 @default.
• W2904327346 hasConcept C112705442 @default.
• W2904327346 hasConcept C126322002 @default.
• W2904327346 hasConcept C126894567 @default.
• W2904327346 hasConcept C168563851 @default.
• W2904327346 hasConcept C181389837 @default.
• W2904327346 hasConcept C22979827 @default.
• W2904327346 hasConcept C2909675724 @default.
• W2904327346 hasConcept C2910800852 @default.
• W2904327346 hasConcept C2911091166 @default.
• W2904327346 hasConcept C31785415 @default.
• W2904327346 hasConcept C33923547 @default.
• W2904327346 hasConcept C40222840 @default.
• W2904327346 hasConcept C71924100 @default.
• W2904327346 hasConcept C90924648 @default.
• W2904327346 hasConcept C98274493 @default.
• W2904327346 hasConceptScore W2904327346C105795698 @default.
• W2904327346 hasConceptScore W2904327346C112705442 @default.
• W2904327346 hasConceptScore W2904327346C126322002 @default.
• W2904327346 hasConceptScore W2904327346C126894567 @default.
• W2904327346 hasConceptScore W2904327346C168563851 @default.

• next